Sinovac Biotech Ltd. extended the termination date of its going-private deal to April 26.
The original termination date was March 26.
The Beijing-based biopharmaceutical company agreed to go private in a $400 million transaction in June 2017. The transaction initially was expected to close in the second half of 2017.